These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 16225469

  • 1. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
    Loria P, Lonardo A, Carulli L, Verrone AM, Ricchi M, Lombardini S, Rudilosso A, Ballestri S, Carulli N.
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
    [Abstract] [Full Text] [Related]

  • 2. Non-alcoholic steatohepatitis and metabolic syndrome.
    Machado M, Cortez-Pinto H.
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
    [Abstract] [Full Text] [Related]

  • 3. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    Tarantino G, Saldalamacchia G, Conca P, Arena A.
    J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
    [Abstract] [Full Text] [Related]

  • 4. Hypertension and fatty liver: guilty by association?
    Brookes MJ, Cooper BT.
    J Hum Hypertens; 2007 Apr; 21(4):264-70. PubMed ID: 17273155
    [Abstract] [Full Text] [Related]

  • 5. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A, Asia-Pacific Working Party for NAFLD.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recent concepts in non-alcoholic fatty liver disease.
    Adams LA, Angulo P.
    Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S, Muratore C, Craxì A.
    Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
    Fan JG.
    J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
    [Abstract] [Full Text] [Related]

  • 14. Metabolic syndrome and NASH.
    Marchesini G, Marzocchi R.
    Clin Liver Dis; 2007 Feb; 11(1):105-17, ix. PubMed ID: 17544974
    [Abstract] [Full Text] [Related]

  • 15. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.
    Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ.
    Scand J Gastroenterol; 2009 Jul; 44(1):6-14. PubMed ID: 18661429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.